Robert van Nostrand

Mr. Robert L.
van Nostrand, CPA, is an Independent Director at SELLAS Life Sciences Group, Inc., an Independent Chairman at Yield10 Bioscience, Inc., a Member at Association of Biofinance Officers and a Treasurer & Director at New York Biotechnology Association, Inc. He is on the Board of Directors at Sellas Life Sciences Group Ltd., SELLAS Life Sciences Group, Inc., ITI, Inc. (New York), Brany LLC, LikeMinds, Inc. (Massachusetts) and New York Biotechnology Association, Inc. Mr. van Nostrand was previously employed as an Independent Director by Enumeral Biomedical Holdings, Inc., a Lead Independent Director by Intra-Cellular Therapies, Inc., a Chief Financial Officer & Executive Vice President by Aureon Laboratories, Inc., a Chief Financial Officer & Executive Vice President by Applied Genetics, Inc. Dermatics, an Independent Director by Achillion Pharmaceuticals, Inc., a Chief Compliance Officer & Senior Vice President by OSI Pharmaceuticals, Inc., a Chief Financial Officer & Executive VP by Applied Genetics, Inc. Dermatics, a Chief Financial Officer & Executive Vice President by Aureon Laboratories, Inc., a Chairman by Farmingdale College Foundation, and a Manager by Touche Ross & Co. He also served on the board at SELLAS Life Sciences Group, Inc. /Old/, Apex Bioventures Acquisition Corp., Apex Bioventures LLC, Achillion Pharmaceuticals, Inc. and Enumeral Biomedical Corp.
He received his undergraduate degree from Long Island University.